Yeji

$ANNX

Annexon, Inc.

Runway:11 mo
NasdaqMarket cap: —CIK 0001528115

Upcoming catalysts

0 surfaced

No catalysts surfaced for ANNX yet.

Drug pipeline

ANX005
Huntington Disease
Vonaprument
Geographic Atrophy
Tanruprubart
Guillain-Barre Syndrome
ANX105
Healthy
ANX1502
Healthy
2.5mg ANX007
Open Angle Glaucoma
ANX009
Lupus Nephritis
ANX007
Open-angle Glaucoma

Recent & active trials

NCTDrugPhaseStatusPrimary completion
NCT07020819TanruprubartPhase 3Recruiting2026-12-31
NCT06510816VonaprumentPhase 3Active Not Recruiting2026-10-31
NCT05521269ANX1502Phase 1Completed2024-11-19
NCT04701164ANX005Phase 3Completed2024-04-20
NCT04569435ANX005Phase 2Completed2024-01-10
NCT05780515ANX009Phase 1Completed2023-08-31
NCT05288881ANX105Phase 1Completed2023-06-19
NCT04656561ANX007Phase 2Completed2023-03-28
NCT04691570ANX005Phase 2Completed2023-01-17
NCT04514367ANX005Phase 2Completed2022-01-28
NCT04535752ANX009Phase 1Completed2021-06-26
NCT04035135ANX005Phase 1Completed2021-05-19
NCT041880152.5mg ANX007Phase 1Completed2019-06-03
NCT03488550ANX007Phase 1Completed2018-08-03
NCT03010046ANX005Phase 1Terminated2018-06-01